The regulation of hepatic Pon1 by a maternal high-fat diet is gender specific and may occur through promoter histone modifications in neonatal rats

Journal of Nutritional Biochemistry

Volumn 25, Issue 2, 2014, Pages 170-176

  Strakovsky, Rita S ^a   Zhang, Xiyuan ^a   Zhou, Dan ^a   Pan, Yuan Xiang ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Developmental programming; Epigenetics; In uterine; Oxidative stress

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; ARYLDIALKYLPHOSPHATASE 3; FATTY ACID; HISTONE H3; HISTONE H4; LYSINE; MANGANESE SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE REPRESSION; GENETIC REGULATION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; LIPID DIET; LIPID LIVER LEVEL; LIPID STORAGE; MALE; MATERNAL NUTRITION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PREGNANCY; PROGENY; PROMOTER REGION; RAT; SEX DIFFERENCE; TRANSCRIPTION INITIATION;

ACETYLATED HISTONE H3; ACETYLATED HISTONE H4; ANTIOXIDANT; AOX; DEVELOPMENTAL PROGRAMMING; DIMETHYLATION OF HISTONE H3 AT LYSINE RESIDUE 4; EPIGENETICS; H3AC; H3K4ME2; H3K9ME3; H4AC; HF; HIGH FAT; IN UTERINE; OXIDATIVE STRESS; PARAOXONASE; PON; SOD; SUPEROXIDE DISMUTASE; TRIMETHYLATION OF HISTONE H3 AT LYSINE RESIDUE 9;

ANIMALS; ANIMALS, NEWBORN; ARYLDIALKYLPHOSPHATASE; BASE SEQUENCE; DIET, HIGH-FAT; DNA PRIMERS; FEMALE; HISTONES; LIVER; MALE; PREGNANCY; PROMOTER REGIONS, GENETIC; RATS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84892547180     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.09.016     Document Type: Article

References (46)

1. Aaltonen J., Ojala T., Laitinen K., Poussa T., Ozanne S., Isolauri E. Impact of maternal diet during pregnancy and breastfeeding on infant metabolic programming: a prospective randomized controlled study. Eur J Clin Nutr 2011, 65:10-19.
2. Bayol S.A., Simbi B.H., Stickland N.C. A maternal cafeteria diet during gestation and lactation promotes adiposity and impairs skeletal muscle development and metabolism in rat offspring at weaning. J Physiol 2005, 567:951-961.
3. Bruce K.D., Cagampang F.R., Argenton M., Zhang J., Ethirajan P.L., Burdge G.C., et al. Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology 2009, 50:1796-1808.
4. Zhang X., Strakovsky R.S., Zhou D., Zhang Y., Pan Y.X. A maternal high-fat diet represses the expression of antioxidant defense genes and induces the cellular senescence pathway in the liver of male offspring rats. J Nutr 2011, 141:1254-1259.
5. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 2011, 26(Suppl 1):173-179.
6. Franco R., Schoneveld O.J., Pappa A., Panayiotidis M.I. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007, 113:234-258.
7. Marra M., Sordelli I.M., Lombardi A., Lamberti M., Tarantino L., Giudice A., et al. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med 2011, 9:171.
8. Shen H., Li M., Wang B., Lai I.K., Robertson L.W., Ludewig G. Dietary antioxidants (selenium and N-acetylcysteine) modulate paraoxonase 1 (PON1) in PCB 126-exposed rats. Environ Sci Pollut Res Int 2013, [Epub ahead of print; http://dx.doi.org.10.1007/S11356-013-1690-1].
9. Precourt L.P., Amre D., Denis M.C., Lavoie J.C., Delvin E., Seidman E., et al. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 2011, 214:20-36.
10. Atamer A., Bilici A., Yenice N., Selek S., Ilhan N., Atamer Y. The importance of paraoxonase 1 activity, nitric oxide and lipid peroxidation in hepatosteatosis. J Int Med Res 2008, 36:771-776.
11. Prakash M., Shetty J.K., Tripathy S., Verma M., Vasudev S., Bhandary P.V. Serum paraoxonase in alcohol abusers associated with alcoholic liver disease. Clin Chim Acta 2007, 378:232-234.
12. Kumon Y., Nakauchi Y., Suehiro T., Shiinoki T., Tanimoto N., Inoue M., et al. Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, downregulate paraoxonase 1 (PON1) expression by HepG2 cells. Amyloid 2002, 9:160-164.
13. Feingold K.R., Memon R.A., Moser A.H., Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 1998, 139:307-315.
14. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998, 101:1581-1590.
15. Bahado-Singh R.O., Schenone M., Cordoba M., Shieh W.S., Maulik D., Kruger M., et al. Male gender significantly increases risk of oxidative stress related congenital anomalies in the non-diabetic population. J Matern Fetal Neonatal Med 2011, 24:687-691.
16. Hirakawa Y., Masuda Y., Kuzuya M., Iguchi A., Kimata T., Uemura K. Impact of gender on in-hospital mortality of patients with acute myocardial infarction undergoing percutaneous coronary intervention: an evaluation of the TAMIS-II data. Intern Med 2007, 46:363-366.
17. Legato M.J. Gender-specific medicine: the view from Salzburg. Gend Med 2004, 1:61-63.
18. Liang Q., Sheng Y., Jiang P., Ji L., Xia Y., Min Y., et al. The gender-dependent difference of liver GSH antioxidant system in mice and its influence on isoline-induced liver injury. Toxicology 2011, 280:61-69.
19. Malorni W., Straface E., Matarrese P., Ascione B., Coinu R., Canu S., et al. Redox state and gender differences in vascular smooth muscle cells. FEBS Lett 2008, 582:635-642.
20. Golab F., Kadkhodaee M., Xu J., Soleimani M. Male susceptibility to hepatic damage in acute uremia in rats. Urology 2011, 78:232.e1-232.e6.
21. Vandegehuchte M.B., Janssen C.R. Epigenetics and its implications for ecotoxicology. Ecotoxicology 2011, 20:607-624.
22. Perera F., Herbstman J. Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol 2011, 31:363-373.
23. Vanhees K., Coort S., Ruijters E.J., Godschalk R.W., van Schooten F.J., Barjesteh van Waalwijk van Doorn-Khosrovani S. Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage. FASEB J 2011, 25:797-807.
24. Hanley B., Dijane J., Fewtrell M., Grynberg A., Hummel S., Junien C., et al. Metabolic imprinting, programming and epigenetics - a review of present priorities and future opportunities. Br J Nutr 2010, 104(Suppl 1):S1-S25.
25. Esteller M. Epigenetics in cancer. N Engl J Med 2008, 358:1148-1159.
26. Aagaard-Tillery K.M., Grove K., Bishop J., Ke X., Fu Q., McKnight R., et al. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol 2008, 41:91-102.
27. Strakovsky R.S., Zhang X., Zhou D., Pan Y.X. Gestational high fat diet programs hepatic phosphoenolpyruvate carboxykinase (Pck) expression and histone modification in neonatal offspring rats. J Physiol 2011, 589:2707-2717.
28. Donkena K.V., Young C.Y., Tindall D.J. Oxidative stress and DNA methylation in prostate cancer. Obstet Gynecol Int 2010, 2010:302051.
29. Lawless M.W., O'Byrne K.J., Gray S.G. Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy. J Cell Mol Med 2009, 13:2800-2821.
30. Soriano F.X., Papadia S., Bell K.F., Hardingham G.E. Role of histone acetylation in the activity-dependent regulation of sulfiredoxin and sestrin 2. Epigenetics 2009, 4:152-158.
31. McCurdy C.E., Bishop J.M., Williams S.M., Grayson B.E., Smith M.S., Friedman J.E., et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009, 119:323-335.
32. Furlong C.E., Suzuki S.M., Stevens R.C., Marsillach J., Richter R.J., Jarvik G.P., et al. Human PON1, a biomarker of risk of disease and exposure. Chem Biol Interact 2010, 187:355-361.
33. Miao B., Zondlo S., Gibbs S., Cromley D., Hosagrahara V.P., Kirchgessner T.G., et al. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J Lipid Res 2004, 45:1410-1417.
34. Gustavsson C., Soga T., Wahlstrom E., Vesterlund M., Azimi A., Norstedt G., et al. Sex-dependent hepatic transcripts and metabolites in the development of glucose intolerance and insulin resistance in Zucker diabetic fatty rats. J Mol Endocrinol 2011, 47:129-143.
35. Gomez-Perez Y., Gianotti M., Llado I., Proenza A.M. Sex-dependent effects of high-fat-diet feeding on rat pancreas oxidative stress. Pancreas 2011, 40:682-688.
36. Bayol S.A., Simbi B.H., Fowkes R.C., Stickland N.C. A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring. Endocrinology 2010, 151:1451-1461.
37. Leviev I., Poirier O., Nicaud V., Evans A., Kee F., Arveiler D., et al. High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients. Atherosclerosis 2002, 161:463-467.
38. Leviev I., Righetti A., James R.W. Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease. J Mol Med 2001, 79:457-463.
39. Suehiro T., Nakamura T., Inoue M., Shiinoki T., Ikeda Y., Kumon Y., et al. A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression. Atherosclerosis 2000, 150:295-298.
40. Gaidukov L., Rosenblat M., Aviram M., Tawfik D.S. The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux. J Lipid Res 2006, 47:2492-2502.
41. Thomas-Moya E., Gomez-Perez Y., Fiol M., Gianotti M., Llado I., Proenza A.M. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress. Obesity (Silver Spring) 2008, 16:2232-2238.
42. Soran H., Younis N.N., Charlton-Menys V., Durrington P. Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol 2009, 20:265-274.
43. Johansson M.B. Lipoproteins and lipids in fetal, neonatal and adult rat serum. Biol Neonate 1983, 44:278-286.
44. Ha H.L., Shin H.J., Feitelson M.A., Yu D.Y. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 2010, 16:6035-6043.
45. Videla L.A. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol 2009, 1:72-78.
46. Murr R. Interplay between different epigenetic modifications and mechanisms. Adv Genet 2010, 70:101-141.